What is Seattle Performance Medicine?
Seattle Performance Medicine operates as a specialized healthcare provider focused on the synthesis of athletic performance metrics and metabolic health diagnostics. The company provides comprehensive services including aerobic and anaerobic evaluation, strength testing, and body composition analysis, while simultaneously addressing complex metabolic conditions such as type 2 diabetes, obesity, and infertility through its affiliate, the Cooper Center for Metabolism. By integrating clinical research with practical patient care, the firm addresses the growing demand for personalized, data-driven health solutions. Its market position is further bolstered by a commitment to public health education, exemplified by the publication of research-backed literature and support for non-profit initiatives aimed at combating metabolic dysfunction.
How much funding has Seattle Performance Medicine raised?
Seattle Performance Medicine has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Seattle Performance Medicine
PPP
Public-Private Partnership
What's next for Seattle Performance Medicine?
With the recent influx of capital, Seattle Performance Medicine is poised to scale its operational infrastructure and enhance its diagnostic capabilities. The strategic roadmap likely involves expanding the reach of the Cooper Center for Metabolism to address the rising prevalence of metabolic syndrome and related health challenges. By prioritizing the integration of advanced metabolic monitoring and athletic performance analytics, the company aims to solidify its leadership in the preventive medicine sector. Future growth will likely focus on increasing patient access to specialized care, refining its proprietary evaluation methodologies, and continuing its advocacy for metabolic health awareness through clinical research and community-focused initiatives.
See full Seattle Performance Medicine company page
